Employees: 1,790
Size Ningxia Yinglite Chemicals (000635.SZ) is a China Materials company (Chemicals: Major Diversified) with a market value of $650M, the 3061st largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥11.00 on 18 Nov 2026.
Performance Over six months the shares gained 35.5%, against -23.6% for the median peer and -20.0% for the China market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue fell 13.8% over the last twelve months (peer median +8.1%); the operating margin is -47.7% (peer median 6.4%).
Valuation It trades at 5.37× book value against a peer median of 2.08× (3rd most expensive of 21).
Price implies The share price implies a return on equity of about 38.3%; Ningxia Yinglite Chemicals delivers -62.2%, so the price asks more than the business earns today.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.51B | CN¥1.71B | CN¥1.85B | CN¥1.75B | CN¥1.86B |
| Revenue growth | — | -7% | +6% | -6% | — |
| Gross profit | -CN¥277M | -CN¥302M | -CN¥262M | -CN¥422M | -CN¥162M |
| EBITDA | n/a | -CN¥279M | -CN¥280M | -CN¥531M | -CN¥345M |
| Net income | -CN¥731M | -CN¥554M | -CN¥503M | -CN¥668M | -CN¥389M |
| Free cash flow | -CN¥555M | -CN¥536M | -CN¥532M | -CN¥670M | -CN¥167M |
| Capital expenditure | CN¥79.6M | CN¥82.8M | CN¥37.8M | CN¥77.9M | CN¥18.9M |
| Total debt | CN¥598M | CN¥677M | CN¥728M | CN¥189M | CN¥13.7M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 000635.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +30.0% | -11.1% | highest of 21 |
| 6-month return | +35.5% | -23.6% | highest of 21 |
| Return on equity | -62.2% | 4.6% | lowest of 21 |
| Price / book | 5.37× | 2.08× | 3rd most expensive of 21 |
| ROE the price implies | 38.3% | 20.9% | 4th most demanding of 21 |
| ROE delivered | -62.2% | 4.6% | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Ningxia Yinglite Chemicals 000635.SZ | China | $650M | +35% | -14% | -62% | 5.37× | 38.3% | -62.2% |
| Shandong Sanyuan Biotechnology 301206.SZ | China | $644M | -21% | +15% | 2% | 1.02× | 8.2% | 1.8% |
| Jiansu Huachang Chemical 002274.SZ | China | $663M | -25% | +9% | -3% | 0.85× | 7.4% | -3.3% |
| Liaoning Oxiranchem,Inc 300082.SZ | China | $673M | -45% | +4% | 4% | 1.59× | 16.8% | 3.8% |
| Hunan Lead Power Technology 300530.SZ | China | $691M | +12% | +16% | -58% | 60.81× | 506.5% | -57.5% |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $697M | -5% | -1% | 1% | 3.83× | 22.8% | 1.0% |
| Shandong Yanggu Huatai Chemical 300121.SZ | China | $703M | -16% | +11% | 4% | 1.27× | 12.4% | 4.4% |
| Ningxia Zhongke Biotechnology 600165.SS | China | $601M | -17% | +8% | -7% | 3.94× | 24.2% | -7.3% |
| Daxin Materials 5234.TW | Taiwan | $705M | -39% | +12% | 26% | 6.54× | 57.7% | 26.2% |
| Shandong Jianbang New Material 603285.SS | China | $594M | -50% | +8% | 8% | 2.25× | 23.6% | 7.9% |
| Hunan Xiangtou Goldsky Titanium Industry Technology 688750.SS | China | $585M | -29% | +4% | 4% | 2.32× | 28.1% | 3.6% |
| Zhejiang Dragon Technology 603004.SS | China | $582M | -22% | -11% | 5% | 1.84× | 19.1% | 4.8% |
| Shandong Taihe Technologies 300801.SZ | China | $582M | -42% | -2% | 5% | 1.44× | 15.3% | 5.2% |
| Archean Chemical Industries ACI.NS | India | $576M | -19% | +6% | 5% | 2.74× | 20.7% | 5.2% |
| Jiangxi Hungpai New Material 605366.SS | China | $736M | -46% | +9% | -6% | 1.87× | 17.4% | -6.5% |
| KH Neochem 4189.T | Japan | $738M | +20% | -6% | 13% | 1.50× | 8.1% | 13.5% |
| JCU 4975.T | Japan | $744M | -34% | +5% | 17% | 2.00× | 21.2% | 16.6% |
| Jiangsu Kuangshun Photosensitivity New Material Stock 300537.SZ | China | $568M | -33% | +15% | 3% | 4.12× | 42.1% | 3.2% |
| Nanjing Well Pharmaceutical 603351.SS | China | $550M | -2% | +7% | 9% | 2.00× | 13.8% | 8.7% |
| Suzhou Highfine Biotech 301393.SZ | China | $786M | -15% | +36% | 5% | 2.17× | 22.2% | 5.1% |
| Ningbo Bohui Chemical Technology 300839.SZ | China | $533M | -35% | +42% | 8% | 4.34× | 29.0% | 8.5% |